A couple hours after taking his first dose of the mind-altering drug 3,4-methylenedioxymethamphetamine, or MDMA, Bessel Van Der Kolk lay down on a couch in the presence of two psychotherapists, put on an eyeshade, and allowed himself to sink into a quiet, hypnotic state.
Wesana Health commences trading on the CSE, symbol "WESA".
It’s been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped his first hit of acid in college and decided to dedicate his life to the healing powers of mind-altering compounds.
Lots of company news. Lots of industry news. Lots of new capital. But no investors. At the moment, they're busy GAMBLING.
Field Trip is now eligible for clearing and settlement through the DTC, boosting liquidity in the stock.
The Texas House of Representatives on Thursday approved to a bill that would require the state to conduct a study into the therapeutic potential of psychedelics like psilocybin and MDMA.
MindMed commences "Project Angie": psychedelic drug R&D aimed at treating pain, involving psychedelics including LSD.
Mydecine announces a new partnership with LeadGen Labs, aimed at improving its drug synthesis operations.
Red Light Holland granted patent pending status for its 'Find Your Dose' microdosing kit.
Psychedelic stocks have become extremely concentrated -- like other sectors. Here's why we see that changing in this sector.
UK-based Small Pharma Inc will commence trading on the TSX Venture Exchange (via RTO) on May 6, 2021, under the symbol "DMT".
Novamind is doubling its Cedar Psychiatry network from four to eight locations, estimating a 325% increase in patient visits.
Psyched Wellness has contracted with a Lithuanian company to obtain 200 kgs of Amanita muscaria mushroom caps.
Field Trip announces the opening of its 5th new U.S. mental health clinic in Houston.
Optimi Health announces its product development agreement with Numinus Wellness is advancing toward a human trial.
